Janux Therapeutics, Inc.
News
Ventures Xi L.P. Avalon Sells 2,182 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX) Stock
Ticker Report Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) major shareholder Ventures Xi L.P. Avalon sold 2,182 shares of the stock in a transaction dated Monday, September 9th. The stock was sold at...\n more…
Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Average Rating of "Moderate Buy" from Analysts
Zolmax Janux Therapeutics, Inc. (NASDAQ:JANX - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the nine analysts that are presently covering the stock, MarketBeat Ratings...\n more…
Stifel Nicolaus Initiates Coverage on Janux Therapeutics (NASDAQ:JANX)
Ticker Report Analysts at Stifel Nicolaus began coverage on shares of Janux Therapeutics (NASDAQ:JANX - Get Free Report) in a research note issued on Friday, Marketbeat Ratings reports. The firm set a "buy" rating...\n more…
Navigating 5 Analyst Ratings For Janux Therapeutics
Benzinga In the latest quarter, 5 analysts provided ratings for Janux Therapeutics JANX, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.\n more…
